Moderna Inc (MRNA.O) on Thursday raised its full-year forecast for sales of its COVID-19 vaccine to roughly $21 billion from $19 billion.
The company in February forecast sales of $19 billion from its signed contracts, and option for $3 billion in additional purchases.
Moderna on Thursday forecast additional purchases of roughly $500 million.
https://www.pharmalive.com/moderna-raises-full-year-covid-vaccine-sales-forecast-to-21-billion/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.